Aviance Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,891
Closed -$308K 243
2016
Q3
$308K Sell
3,891
-18,793
-83% -$1.53M 0.01% 300
2016
Q2
$1.89M Sell
22,684
-14,624
-39% -$1.3M 0.06% 146
2016
Q1
$3.43M Sell
37,308
-4,164
-10% -$376K 0.11% 117
2015
Q4
$4.2M Buy
41,472
+23,796
+135% +$2.48M 0.14% 104
2015
Q3
$1.74M Sell
17,676
-13,443
-43% -$1.49M 0.06% 130
2015
Q2
$3.64M Buy
31,119
+14,192
+84% +$1.55M 3.74% 5
2015
Q1
$1.66M Sell
16,927
-871
-5% -$88.4K 0.06% 126
2014
Q4
$1.68M Buy
17,798
+114
+0.6% +$11.8K 0.06% 151
2014
Q3
$1.88M Sell
17,684
-10,263
-37% -$1M 0.08% 144
2014
Q2
$2.32M Buy
27,947
+4,384
+19% +$341K 0.1% 118
2014
Q1
$1.67M Buy
23,563
+22,758
+2,827% +$1.78M 0.08% 114
2013
Q4
$60K Buy
805
+58
+8% +$4.04K 0.03% 216
2013
Q3
$47K Sell
747
-485
-39% -$29K 0.03% 215
2013
Q2
$63K Buy
+1,232
New +$64.2K 0.03% 212

Other funds holding GILD

Aviance Capital Management's GILD Position: Q4 2016 in Review

Aviance Capital Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 3,891 shares — an estimated $308K sold.

Aviance Capital Management first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $4.2M in Q4 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Aviance Capital Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Aviance Capital Management sold 3,891 Gilead Sciences shares in Q4 2016, an estimated $308K.
  • Aviance Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
  • Aviance Capital Management's Gilead Sciences position peaked at $4.2M in Q4 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Aviance Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.